⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Olpha (JSC Olpha) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Olpha (JSC Olpha)
↗Olaine, Latvia
Olpha, formerly known as JSC Olainfarm, is a leading pharmaceutical manufacturer in the Baltic States with over 50 years of experience. The company specializes in the production of Active Pharmaceutical Ingredients (APIs), intermediates, and finished dosage forms (FDFs), with a strong focus on neurology, cardiology, infectology, and allergology.
Headquartered in Olaine, Latvia, the company operates a global network with subsidiaries and representative offices across Europe, Central Asia, and beyond. Olpha is committed to high-quality manufacturing, holding EU GMP, U.S. FDA, and other international certifications, and is currently pursuing an ambitious growth strategy to become a top-ten pharmaceutical company in Europe.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Manufacturing
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$200M
Founded:1972
Ownership:private
Status:operating
FUNDING
Investors:JSC AB City
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:JSC AB City
Subsidiaries:Silvanols, Tonus Elast, Rīgas Farmaceitiskā Fabrika, Jonnex-Farma, Olpha France, Olpha Germany GmbH, Olpha Poland sp., Olpha Italy srl, OLPHA PHARMA SPAIN, S.L.
Key Partnerships:Novartis, Dr. Reddy's, Glenmark Generics, Teva, Egis
COMPETITION
Position:Leader
Competitors:Grindeks
LEADERSHIP
Key Executives:
Juris Hmeļņickis - Chairman of the Board
LINKS
Website:olpha.eu
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Olpha (JSC Olpha). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.